Conexeu Sciences is trading 10.29% up at $4.02, alongside broader biotech-sector strength. - On October 15, 2026, the XBI was reported up 2.20%; positive clinical data and regulatory news contributed to the sector’s supportive tone. - No new company-specific announcement was identified for the date. The latest located update, on October 6, concerned advancing Ten Minute Tissue toward a planned FDA 510(k) submission.